An implementation science approach to address multi-level barriers to cancer screening among women living with HIV in South Africa
An implementation science approach to address multi-level barriers to cancer screening among women living with HIV in South Africa
批准号:
10242935
负责人:
Carla J Chibwesha
金额:
$14.56万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-14 至 2023-06-30
关键词:
Acquired Immunodeficiency SyndromeAddressAdoptedAdultAffectAfricaAfrica South of the SaharaAfricanAgeBayesian MethodCancer BurdenCancer ControlCancer EtiologyCaringCessation of lifeClinicalCommunitiesDataDiagnosisDrug InteractionsEarly DiagnosisEducational workshopEnrollmentEpidemicFocus GroupsFundingGoalsHIVHIV InfectionsHealthHealth PersonnelHealth systemHuman papilloma virus infectionIncidenceInterventionInterviewLeadLife ExpectancyMalignant NeoplasmsMalignant neoplasm of cervix uteriMethodsModelingOutcomeParticipantPatientsPhasePoliciesPolicy MakerPrevention ResearchProviderPublic HealthPublic SectorReportingResearchResearch InfrastructureResourcesRiskScienceScreening for cancerServicesSiteSouth AfricaSouth AfricanTestingThinkingTimeTrainingWomanWorkacceptability and feasibilityantiretroviral therapybasebreast and cervical cancer screeningcancer health disparitycancer preventioncare seekingchemotherapeutic agentcivil societycohortcontextual factorsdesigndisparity eliminationexperimental studyhigh risk populationimplementation scienceimplementation trialimprovedinnovationlow and middle-income countriesmalignant breast neoplasmmenmortalitypreferencepreventpreventable deathprogramsrecruitscreeningscreening servicessimulationsocialtooltreatment programuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Over the next 20 years, cancer incidence and mortality are expected to rise at staggering rates worldwide, with
much of the burden concentrated in low- and middle-income countries (LMICs). Despite widescale availability of
antiretroviral therapy (ART) in LMICs, women living with HIV remain vulnerable to both AIDS- and non-AIDS
defining cancers such as cervical and breast cancer. This is because screening coverage for breast and cervical
cancer is low – and access to timely diagnosis and treatment is limited. In South Africa, for example, fewer than
one-third of HIV-infected women undergo breast and cervical cancer screening at the recommended intervals.
Attrition between cancer screening and treatment is also substantial among HIV-infected women in under-
resourced South African settings. We seek to eliminate disparities in breast and cervical cancer outcomes among
HIV-infected women in South Africa. In this application, we propose an innovative implementation science
project to close the gap between cancer control policy and cancer screening practices in this high-risk
population. Specific Aim 1 will use a sequential mixed-methods design consisting of focus groups, a discrete
choice experiment (DCE), and in-depth interviews to study multi-level drivers of cancer screening and
determine women’s preferences for cancer screening services. We will enroll 80 HIV-infected women and 32
men in 14 focus groups (8 participants in each group), 600 HIV-infected women in the DCE, and conduct 24 in-
depth interviews with key stakeholders. In Specific Aim 2, we will co-create a multi-level intervention package
with patients, providers, and policy makers, applying Design Thinking principles to design the package and
assess its acceptability. We anticipate that the package will include training, clinical tools, and user-focused
interventions applied at various levels of the Social Ecological Model to address the barriers identified in Aim 1.
We will explore acceptability of the intervention package through user pre-testing workshops conducted with 6
user groups: 2 groups of HIV-infected women, 2 of healthcare providers, and 2 of policy makers. This project will
provide robust preliminary data to inform larger-scale implementation trials to (1) promote uptake of cancer
screening among women living with HIV and (2) improve retention in care for women who screen positive. We
will leverage longstanding partnerships and a strong research infrastructure in Johannesburg to implement the
proposed work.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)
-
批准号:10544391
-
项目类别:
-
资助金额:$70.22万
-
财政年份:2022
-
负责人:Carla J Chibwesha
-
依托单位:
Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)
-
批准号:10707249
-
项目类别:
-
资助金额:$65.01万
-
财政年份:2022
-
负责人:Carla J Chibwesha
-
依托单位:
The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.
-
批准号:10428019
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa
-
批准号:10652369
-
项目类别:
-
资助金额:$109.71万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Performance of different sample types for high-risk human papillomavirus testing and genotyping for the detection of high grade cervical intraepithelial neoplasia
-
批准号:10623831
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Project 1: Urine sampling for HPV infection and methylation testing for cervical cancer screening among women living with HIV in Malawi and South Africa
-
批准号:10652392
-
项目类别:
-
资助金额:$22.81万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa
-
批准号:10238155
-
项目类别:
-
资助金额:$110.9万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV
-
批准号:10675732
-
项目类别:
-
资助金额:$63.86万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV
-
批准号:10165676
-
项目类别:
-
资助金额:$47.29万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Project 1: Urine sampling for HPV infection and methylation testing for cervical cancer screening among women living with HIV in Malawi and South Africa
-
批准号:10434863
-
项目类别:
-
资助金额:$22.81万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa
-
批准号:10084552
-
项目类别:
-
资助金额:$118.05万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV
-
批准号:10411963
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa
-
批准号:10434858
-
项目类别:
-
资助金额:$110.19万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Project 1: Urine sampling for HPV infection and methylation testing for cervical cancer screening among women living with HIV in Malawi and South Africa
-
批准号:10084557
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Project 1: Urine sampling for HPV infection and methylation testing for cervical cancer screening among women living with HIV in Malawi and South Africa
-
批准号:10238160
-
项目类别:
-
资助金额:$22.81万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV
-
批准号:10013629
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2020
-
负责人:Carla J Chibwesha
-
依托单位:
海外基金